Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

The end of hepatitis C?

Next-gen hep C therapies may see the disease's global elimination - but treament access must be stepped up dramatically

- PMLiVE

FDA grants orphan drug status to Treeway’s ALS treatment

Amyotrophic Lateral Sclerosis drug TW001 gainsregulatory benefits

- PMLiVE

Pricing pressures preventing UK access to MenB vaccine

GlaxoSmithKline’s Bexsero will need a dramatic price cut to gain NHS entry

- PMLiVE

UCB: Patient centricity should move a business forward

Pharma may become obsolete if it does not include the patient voice, says Lode Dewulf

Biogen Idec building

Biogen Idec claims first with Alzheimer’s candidate

Aducanumab slowed down impairment in cognition and memory in early stages

- PMLiVE

Boehringer to move psoriasis programme into phase III

Candidate outperformed J&J’s rival Stelara 

Eli Lilly HQ

Lilly signs cancer pact with Chinese biotech

Marks first major deal between a Western pharma company and a Chinese biotech

- PMLiVE

MHP Health strengthens team with four hires

Kate Pogson joins firm as its new director and joins three further appointments

- PMLiVE

Neurodegenerative research needs better cooperation, say GlobalData

And public funding must be provided to eradicate business risks

Curbing the rise of drug resistance

The pharma sector could hold the greatest power to address the global threat of antimicrobial resistance

Actavis makes two additions to board of directors

Michael R Gallagher and Peter J McDonnell join

Understanding the ‘adoption ladder’ in closed loop marketing

Did you know that the very barriers to your product can be turned around to drive its success? Learn the judo strategy that is at the heart of great e-detailing.

Anthill Agency

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links